Launch price: $32 a month, locked for as long as you stay.

Free tracked US shipping. 90-day money-back guarantee.

Get my patches

Research library

Berberine: the history, the chemistry and the research

A sourced, plain-English library on one of the most-studied plant compounds, including what the evidence does not show.

Last updated: November 17, 2026

How to read this page. This is our research library, not a product page. Every human study here used berberine taken by mouth, typically 900–1,500 mg a day. The Berberine Patch is a topical cosmetic; it hasn’t been tested in clinical trials, and we don’t claim it delivers berberine into the body or produces any result described below. Animal and cell findings often don’t carry over to people.

Two thousand years of goldthread

Berberine is the bright-yellow alkaloid that colors the roots, rhizomes and bark of several unrelated plants: Chinese goldthread (Coptis, “Huang Lian”), Indian barberry (Berberis aristata, Sanskrit Dāruharidrā, “wood turmeric”), European barberry (Berberis vulgaris), goldenseal (Hydrastis canadensis), Oregon grape (Mahonia) and the Amur cork tree (Phellodendron amurense).1 Huang Lian appears in the Shennong Bencao Jing, compiled in the Eastern Han dynasty (25–220 CE); around 500 CE the Mingyi Bielu first linked it to xiaoke, a “wasting-thirst” syndrome, a historical record rather than proof of anything.1

Chemists isolated the molecule three times under three names, “jamaicine” (1824), “xanthopicrite”, Greek for yellow-bitter (1826), and finally “berberine” (1830), after the barberry, before realising in 1862 that all three were the same compound.2

The molecule

FormulaC₂₀H₁₈NO₄⁺ (a permanently charged quaternary alkaloid)
Molar mass336.4 g/mol
StructureFive rings, 25 heavy atoms, largely flat
As a dyeBerberine chloride is Natural Yellow 18 (C.I. 75160)
FluorescenceYellow-green, emission ≈ 530–556 nm; strongest when bound to DNA, heparin or plant tissue
IdentifiersPubChem CID 2353 · CAS 2086-83-1

Its fluorescence is useful: botanists have used berberine since 1988 to make suberin and lignin glow in plant cell walls.3 And in 2024, researchers found that goldthread and the Amur cork tree build berberine’s signature “bridge” with entirely different enzymes, a flavin-dependent enzyme in one and a cytochrome P450 in the other: nature invented the same molecule twice.4

The research ledger

Every entry is labelled by the kind of evidence it is. We include results that disappoint as well as ones that impress.

YearStudyWhat it foundEvidence
2004Kong et al., Nature MedicineIn human liver cells, berberine raised LDL-receptor levels by stabilising its mRNA, a mechanism distinct from statins. Hamsters showed more liver LDL receptors, and an uncontrolled group of 32 patients taking oral berberine saw LDL-C fall 25% over 3 months.Cell · Animal · Human (oral)
2006Lee et al., DiabetesBerberine activated AMPK, the cell’s energy sensor, in fat and muscle cells, with metabolic effects in diabetic and insulin-resistant rodents.Cell · Animal
2008Zhang et al., JCEMIn 116 adults with type 2 diabetes and dyslipidaemia, oral berberine 1 g/day for 3 months lowered HbA1c (7.5% → 6.6%), fasting glucose and LDL-C versus placebo.Human (oral)
2008Yin et al., MetabolismIn 36 newly diagnosed adults, oral berberine 0.5 g three times daily lowered glucose similarly to metformin over 3 months. Transient digestive side effects were common.Human (oral)
2015Feng et al.Gut bacteria convert berberine into dihydroberberine, which animals absorb about five times better, before it turns back into berberine.Animal
2015Yu et al.In human gut-lining cells, berberine triggered GLP-1 release through the bitter-taste receptor TAS2R38. This is a gut-surface mechanism.Cell
2020Chen et al., Lancet Gastroenterol HepatolIn a 1,108-person double-blind trial, oral berberine 0.3 g twice daily reduced colorectal adenoma recurrence after polyp removal: 36% vs 47%.Human (oral)
2023Blais et al.Across 18 placebo-controlled trials (1,788 adults), oral berberine lowered LDL-C by 0.46 mmol/L. The authors describe the effect as small.Human (oral)
2024Wang et al.Across 50 trials (4,150 people with type 2 diabetes), oral berberine, alone or with diabetes medicines, improved glucose and lipid markers at 0.9–1.5 g/day.Human (oral)
2024Xu et al., Science AdvancesTwo distant plant lineages evolved different enzymes to make berberine: convergent evolution.Plant biochemistry
2025Liu et al.In 12 placebo-controlled trials in metabolic syndrome (889 people), oral berberine reduced triglycerides, fasting glucose and waist circumference, with no effect on HDL or blood pressure.Human (oral)
2025Xiao et al.At 10 μM, berberine extended healthy lifespan in the worm C. elegans via the PMK-1/SKN-1 stress pathway.Animal
2026Elahi Vahed et al.A meta-analysis of 23 trials found oral berberine reduced body weight by 0.88 kg and BMI by 0.48 kg/m² on average: real, but modest.Human (oral)
2026Lei et al., JAMA Network OpenIn 337 adults over six months, oral berberine 1 g/day did not reduce visceral or liver fat, its main outcomes. LDL, apoB and hs-CRP fell modestly.Human (oral)
2025Shi et al.Of 54 systematic reviews of berberine, only one was rated high quality. Better trials are still needed.Evidence quality

What about patches?

No published human study has measured blood levels, or any health outcome, from a berberine skin patch. Transdermal results so far come from animals, excised skin and formulation labs: in rats, a 5% berberine cream (not a patch) produced higher blood exposure than the same dose by mouth, in a small study run by the cream’s manufacturer;5 microneedles have carried berberine into skin layers in the lab.6 Berberine is small enough to be a candidate for skin delivery (336 Da), but it is permanently charged and water-loving, which skin resists. Some of what oral berberine does may also happen in the gut itself, which a patch bypasses. So oral results can’t be transferred to a patch. That is why we sell The Berberine Patch as a daily cosmetic patch and make no health claims for it.

Safety, in plain words

In oral studies, 0.9–1.5 g a day was generally well tolerated; the commonest problems were digestive. Oral berberine inhibits the liver enzymes CYP3A4, CYP2D6 and CYP2C9 and has raised cyclosporine levels in transplant patients; it may add to the effect of glucose-lowering medicines. It must not be used in pregnancy, breastfeeding, newborns or children because it can displace bilirubin. On skin, berberine is a photosensitiser in lab tests and a yellow dye. Read our full safety page before use, and talk to your doctor if you take any medication.7

Timeline

AntiquityDaruharidra, the 'wood turmeric'. Classical Ayurvedic texts, including the Caraka-samhita, use Daruharidra (Sanskrit 'wood' + 'turmeric'), identified as Berberis aristata, the Indian barberry. Exact text dates are debated. Source
Eastern Han (25–220 CE)Huang Lian enters the Shennong Bencao Jing. Coptis rhizome (Huang Lian) is recorded in the Shennong Bencao Jing, China's earliest surviving materia medica, compiled during the Eastern Han dynasty. Source
c. 500 CEFirst link to 'wasting-thirst'. The Mingyi Bielu (Records of Famous Physicians), attributed to Tao Hongjing, first describes Coptis for xiaoke, a wasting-thirst syndrome; Tang-dynasty texts repeat the association. Source
1824'Jamaicine' from Caribbean bark. Hüttenschmid extracts a substance he calls jamaicine from the bark of Geoffroya inermis; later chemists accepted it as berberine. Source
1826Chevallier and Pelletan's 'xanthopicrite'. Chevallier and Pelletan isolate a yellow alkaloid from the bark of Zanthoxylum clava-herculis and name it xanthopicrite (Greek roots: 'yellow' + 'bitter'). Source
1830Named 'berberine' after the barberry. Buchner and Herberger give the name berberine to a purified extract of barberry, Berberis vulgaris. Some sources date this to 1832 or 1835. Source
1862Three names, one molecule. English chemist J. Dyson Perrins shows xanthopicrite is identical with berberine and identifies berberine in goldenseal (Hydrastis canadensis). Source
1988A glowing stain for plant cell walls. Brundrett, Enstone and Peterson publish a berberine–aniline blue fluorescent staining method for suberin, lignin and callose in plant tissue. Source
2004A cholesterol mechanism unlike statins. Kong et al. (Nature Medicine) report berberine raises liver LDL-receptor levels by stabilising its mRNA, in hamsters and liver cells, plus a 32-patient oral study. Source
2008Placebo-controlled oral trial in type 2 diabetes. Zhang et al. randomise 116 patients to oral berberine 1 g/day or placebo for 3 months; HbA1c falls from 7.5% to 6.6% with berberine. Source
2015Gut microbes unlock absorption. Feng et al. show gut-bacterial nitroreductases convert berberine to dihydroberberine, absorbed about five times better in animals, then re-oxidised to berberine. Source
2020Large polyp-prevention trial. In a 1,108-person Chinese RCT, oral berberine 0.3 g twice daily cut adenoma recurrence after polypectomy: 36% versus 47% on placebo. Source
2024Nature invented berberine twice. Science Advances: Phellodendron builds berberine's key 'bridge' with a cytochrome P450 (CYP71BG29), whereas Coptis uses a flavin-dependent enzyme — convergent evolution. Source
2026A sobering 337-person trial. JAMA Network Open: six months of oral berberine 1 g/day did not reduce visceral or liver fat; LDL, apoB and hs-CRP fell modestly. Source

Sources

  1. Wang J et al. Clinical evidence and the historical use of Coptis. 2014. PMID 24818152; Feng X et al. Theranostics 2019. doi:10.7150/thno.30787
  2. Lloyd JU, Lloyd CG. Drugs and Medicines of North America (1884–87); King’s American Dispensatory (1898). henriettes-herb.com
  3. Brundrett MC, Enstone DE, Peterson CA. Protoplasma 1988;146:133–42. doi:10.1007/BF01405922
  4. Xu et al. Convergent evolution of berberine biosynthesis. Science Advances 2024. PMID 39612339
  5. Buchanan B et al. 2018. PMID 29579096
  6. Cui et al. 2024. PMID 39400576
  7. NIH NCCIH, Goldenseal. nccih.nih.gov; Yan HM et al. 2015 PMID 26252777